Not available
Quote | Portola Pharmaceuticals Inc. (NASDAQ:PTLA)
Last: | $18.03 |
---|---|
Change Percent: | 0.22% |
Open: | $18 |
Close: | $18.03 |
High: | $18.07 |
Low: | $17.99 |
Volume: | 8,075,249 |
Last Trade Date Time: | 07/01/2020 04:55:56 pm |
News | Portola Pharmaceuticals Inc. (NASDAQ:PTLA)
The "Tesla Test" looks for the rare combination of forensic scores that preceded a 40% drop in TSLA stock in a prior ad-hoc study forecasting many other stock declines since. This ongoing test of 22 adverse fundamental forensic and value ratios across four accounting algorithms resume...
Merger activity remained steady last week with one new deal announced, six deals closing and one deal called off. The month of June ended with six active deals being completed and another deal terminated, resulting in a total of five deals terminated in a single month. June was also the most...
Message Board Posts | Portola Pharmaceuticals Inc. (NASDAQ:PTLA)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $PTLA great article | whytestocks | investorshangout | 05/14/2020 4:10:50 PM |
That's why he is not your boss. | TrendVestor | investorshub | 05/06/2020 5:18:58 AM |
So I was off by a few bucks. | NYCPuglet | investorshub | 05/05/2020 1:56:12 PM |
It was only between 20-40 then | europtiger | investorshub | 05/05/2020 1:46:21 PM |
whytestocks: $PTLA News Article - WeissLaw LLP: Portola Pharmaceuticals, Inc. is the Subject of a Le | whytestocks | investorshangout | 02/03/2020 7:40:42 PM |
News, Short Squeeze, Breakout and More Instantly...
Portola Pharmaceuticals Inc. Company Name:
PTLA Stock Symbol:
NASDAQ Market:
Portola Pharmaceuticals Inc. Website:
SOUTH SAN FRANCISCO, Calif. , May 18, 2020 /PRNewswire/ -- Portola Pharmaceuticals, Inc. ® (NASDAQ: PTLA) today announced that, due to the public health impact of the coronavirus (COVID-19) pandemic and to prioritize the health and well-being of stockholders, employees and othe...
SOUTH SAN FRANCISCO, Calif. , May 14, 2020 /PRNewswire/ -- Portola Pharmaceuticals, Inc. ® (Nasdaq: PTLA) announced that the U.S. Centers for Medicare & Medicaid Services (CMS) has proposed extending the New Technology Add-on Payment (NTAP) for Andexxa ® [coagula...
SOUTH SAN FRANCISCO, Calif. , May 11, 2020 /PRNewswire/ -- Portola Pharmaceuticals, Inc. ® (Nasdaq: PTLA) today reported financial results for the three months ended March 31, 2020, and provided a corporate update, including the Company's actions to continue to su...